Daftar ini adalah analisis berdasarkan peristiwa pasar terbaru. Ini bukan rekomendasi investasi.
Tentang
GlaxoSmithKline Consumer Healthcare Limited manufactures and sells malt based foods, protein rich foods, and cereal based beverages in India. The company offers health food drinks and biscuits under the Horlicks, Boost, Viva, and Maltova brand names; Ostocalcium, a calcium supplement; ENO, an antacid for acidity; Crocin, a non?prescription analgesics drug; and Iodex, a balm for neck/shoulder pain, back pain, joint pain, sprain, etc. It also provides Crocin Cold & Flu, which provides relief from headache, body aches and pains, and sore throat, as well as pain associated with sinusitis, nasal, and sinus congestion; and Otrivin, a nasal decongestant that provides relief from blocked nose. In addition, the company offers toothpaste for sensitive teeth under the Sensodyne name; and prescription medicines for a range of therapeutic areas, as well as vaccines for the prevention of life-threatening diseases. It also exports its products to Bangladesh, Sri Lanka, the Middle East, Myanmar, Kenya, Mauritius, and Pakistan. GlaxoSmithKline Consumer Healthcare Limited has a strategic collaboration with InveniAI LLC. GlaxoSmithKline Consumer Healthcare Limited was incorporated in 1958 and is headquartered in Gurugram, India.
Show more...
CEO
Mr. Navneet Saluja
Karyawan
3844
Negara
IN
ISIN
INE264A01014
Pencatatan
0 Comments
Bagikan pendapatmu
FAQ
Berapa harga saham GlaxoSmithkline Consumer Healthcare hari ini?▼
Harga saat ini dari GSKCONS.NSE adalah ₹10,675.5 INR — naik sebesar +4.29% dalam 24 jam terakhir. Pantau kinerja harga saham GlaxoSmithkline Consumer Healthcare lebih dekat di grafik.
Apa simbol saham GlaxoSmithkline Consumer Healthcare?▼
Tergantung pada bursa, simbol saham dapat berbeda. Misalnya, di bursa , saham GlaxoSmithkline Consumer Healthcare diperdagangkan dengan simbol GSKCONS.NSE.
Bagaimana laporan keuangan GlaxoSmithkline Consumer Healthcare pada kuartal lalu?▼
Laporan keuangan GSKCONS.NSE untuk kuartal terakhir adalah 45.75 INR per saham, sedangkan perkiraannya 46.93 INR, menghasilkan kejutan sebesar -2.51%. Perkiraan laba untuk kuartal berikutnya adalah N/A INR per saham.
Berapa pendapatan GlaxoSmithkline Consumer Healthcare tahun lalu?▼
Pendapatan GlaxoSmithkline Consumer Healthcare tahun lalu berjumlah 25.39B INR.
Berapa pendapatan bersih GlaxoSmithkline Consumer Healthcare tahun lalu?▼
Pendapatan bersih GSKCONS.NSE untuk tahun lalu adalah 5.93B INR.